Bosakitug (ATI-045, TQC2731) is a humanized anti-TSLP monoclonal antibody currently in development for atopic dermatitis (NCT07011706), asthma (NCT06829784), and COPD (NCT06707883). Here, TSLP is linked to chronic obstructive pulmonary disease.